Riskpilot← Back to searchSign inGet full accessSlutplattan SOVGI 113114 AB
ABDissolvedOrg 5568027733Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20102 employees
Revenue 2021
SEK 426K
-66% vs 2020
EBITDA margin
37.3%
+131% vs 2020
Equity ratio
85.9%
Financial strength
Net profit 2021
SEK 158K
+130% vs 2020
| Revenue | SEK 426K | -66% |
| EBITDA | SEK 159K | +131% |
| Net profit | SEK 158K | +130% |
| Total assets | SEK 290K | +26% |
| Equity | SEK 249K | +174% |
| Employees | 2 | — |
Legal name
Slutplattan SOVGI 113114 AB
Org number
5568027733
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
24 mars 2010
Share capital
SEK 0
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Company purpose
Föremålet för bolagets verksamhet är att äga och förvalta fast och lös egendom samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 889 | 2 554 | 2 136 | 1 252 | 426 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −36 | 236 | −160 | −520 | 159 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −36 | 236 | −160 | −520 | 159 |
| Net financials | — | — | — | — | −1 |
| Profit before tax | −36 | 236 | −160 | −520 | 158 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −36 | 236 | −160 | −520 | 158 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 682 | 1 130 | 743 | 231 | 290 |
| Equity | 536 | 772 | 612 | 91 | 249 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 147 | 359 | 131 | 140 | 41 |
| Total debt | 147 | 359 | 131 | 140 | 41 |
EBITDA margin
37.3%
This company
15.8%
Market median
+136% vs market
20172021
Equity ratio
85.9%
This company
38.2%
Market median
+125% vs market
20172021
Return on equity
63.5%
This company
18.4%
Market median
+245% vs market
20172021
Net profit margin
37.1%
This company
8.1%
Market median
+358% vs market
20172021
Asset turnover
1.47×
This company
1.12×
Market median
+31% vs market
20172021
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
AC | Audit | 2022 – 2022 |
TA | Audit | 2022 – 2022 |
CF Auditor Substitute | Auditor Substitute | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
| Board of Directors | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
FW | Deputy Board Member | 2022 – 2022 |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Slutplattan SOVGI 113114 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Carina Christiansson | Audit | 0 companies |
| Tord Arne Ragnar Olsson | Audit | 0 companies |
| Carl Fredrik Johan Gustav Waern | Auditor Substitute | 0 companies |
| Cunliang Liu | Board of Directors | 0 companies |
| Bo Torsten Nilsson | Board of Directors | 0 companies |
| Bo Torsten Patrik Nilsson | Deputy Board Member | 0 companies |
| Fang Wu | Deputy Board Member | 0 companies |